In the rapidly evolving landscape of biotech innovation, a seismic shift is underway—one that could redefine the very foundation of how biologics are developed, protected, and monetized. The recent landmark case of Amgen v. Sanofi has sent ripples thro…

In the high-stakes world of biotech innovation, a seismic shift is underway—one that could redefine the landscape of biologic drug development and patent strategy for years to come. The recent landmark case of Amgen v. Sanofi has sent ripples through t…

In the relentless race to innovate and capture market share, pharmaceutical companies often employ strategies that go beyond traditional R&D and marketing. One such tactic gaining increasing scrutiny is drug product hopping—a practice that, while l…

In the fiercely competitive landscape of pharmaceutical innovation, small molecule drugs continue to be the backbone of therapeutic breakthroughs. Yet, with patent cliffs looming and generic competition accelerating, how can biotech and pharma companie…

In the rapidly evolving landscape of global healthcare, Africa is emerging as a pivotal frontier—not just for its demographic and economic potential, but for its strategic importance in pharmaceutical innovation and market dominance. A recent in-depth …

In the rapidly evolving landscape of pharmaceuticals, the ability to adapt and innovate is no longer optional—it’s essential. A recent deep dive by Drug Patent Watch sheds light on a critical strategic challenge facing pharma companies today: mastering…

In the high-stakes world of pharmaceutical innovation, patent strategies have become a double-edged sword—protecting groundbreaking therapies while simultaneously creating formidable barriers that delay generic competition and keep drug prices high. Th…

In the high-stakes world of pharmaceutical innovation, the recent legal battle between Novartis Pharmaceuticals and Apotex Inc. underscores a critical reality: the delicate balance between protecting intellectual property and fostering competition that…

In the high-stakes world of pharmaceuticals, innovation is only part of the story. The true game-changer often lies in strategic patent management—particularly the savvy extension of patent life that can turn a blockbuster drug into a prolonged revenue…

In the high-stakes world of pharmaceuticals, the “patent cliff” isn’t just a looming threat—it’s a seismic event capable of reshaping company trajectories overnight. As blockbuster drugs face patent expiration, pharma executives are racing against time…